Member Info for PompeyMagnus

Interesting read. Article also states neither SAV nor any of its employees subject of investigation, and that activities continue unencumbered. The pinsent article interesting, too: perhaps no surprises that Portugal only mid table when it comes to public sector corruption (scores 62/100). Hope to god no one's been greasing palms or cutting corners. It all increases uncertainty. Potential election, potential policy change, plus how long's the investigation going to take.

https://www.reuters.com/world/europe/portuguese-prosecutors-search-government-buildings-lithium-investigation-2023-11-07/

Just added some more on the back of the rns. Hoping this will continue its nice run. Wonder if we'll see a divi in next 2 years.

Very slow burner. Maybe 5 or ten years for a return. In the meantime: Ana Developments. Should be Ana Development: seem like a one club golfer now, I'm afraid. Would be more encouraging if we heard more about think tank and lobbying taking place to further change the HMG mindset about cannabis and how Ana is linking with this. Who's ears at HMG are ANA bending, directly or indirectly, to get NHS prescribing started?

I wish to thank Melissa for responding to my RNS post. I found her response helpful and clarifying and wish to thank her for taking the time to do so. I think her reminder that farmer and pharma are both risky was a useful reality check for me. I'm hoping one of ANA'S plays is a coordinated think tank/lobbying pitch to HMG (Hunt and Badenoch) to encourage them to take MC seriously l, if they arent doing so now, and for their agencies and trusts to do likewise. Don't we need this economic growth, after all?

Disappointing RNS in my view. From big farmer to high risk micro pharma in a paragraph. What happened to all those tonnes of product they were going to grow. They don't even seem to have a drive to compete in the export market and try to tap into growth outside the UK. We're in the hands of a bottle of mrx and white coated academics now. Heaven help us. A company no longer master of its own destiny and a hostage to fortune.

Not a very encouraging RNS. The strain stabilisation still not going well and taking a long time: 5 generations at 8-months each is 4 years! Wonder if they're trying too much innovation and experimentation with the current generational approach. Perhaps they need to give it the elbow and do it the more conventional way (gene/tissue) that others already seem to have done. Also, nothing in terms of even a guide/outline timetable. Only bit of good news is the growing climate and, let's face it, Mother Nature is the reason for that. Back in the biscuit tin for another few years.

Equity raises all part of buying shares in a high risk play like GMS which, according to its last terrible RNS, is still in the deep **** it chose to splash all over note 2 in that RNS. Share price could drop by 50%+ on a raise. Only way they can get buyers to come on board is with a massive discount. Traders then take price back up to pre-raise price about 6 months later, assuming a fair wind, then take profits, so price then just ranges. I'm a buy and holder 5 years plus. Have got 3 more to go. Fingers crossed that by 2025 we may have had some real turnaround performance. In the meantime, fill your boots on the raise announcement and drop!

2nd equity raise still there, even though recent glossy article on Gms didnt mention and will have reeled in buyers no doubt. Plus it's not confidence instilling to see all that risk register stuff in Note 3; all companies have risk registers, but must confess I wasn't aware you had to plaster them all over your RNSs; thought they're for internal consumption only; let's face it, all kinds of **** can happen to any company at any time and it's up to the BOD to mitigate them. I'll continue to hold because of the continued improvement in debt, profitability and utilisation. Plus the biggy for me is the off shore renewables potential which must surely be significant going forward, although wasn't explicitly mentioned. Back in the biscuit tin for the foreseeable.

Thanks for posting the article. Have to say that's the most positive thing I've read about GMS in years, and not before time!! It didn't say anything about the 2nd equity raise though? Has the need for the raise now fallen away due to the improving debt position?

Apologies for asking a question I feel I should know the answer to: does anyone know if the former CEO, DA, has held on to his shareholding or if he sold in whole or in part when he resigned? Thank You.

Check this link out (hit no.1 on Google): it's lithium mining using salt flats and water evaporation, eg in South America, which is the real issue, less so the ore mining kind, eg at MDB. The ore mining process seems to be part of the solution rather than the problem? This is a mining publication so no doubt there's some bias but it does seem balanced to me in fairness.

https://www.mining-technology.com/analysis/lithiums-water-problem/

Good RNS today. New contract wins. On course if not ahead of business plan. Increasing earnings. 78% vessel utilisation for year already plus buoyant tender pipeline. Would like to hear more on equity raise but think this is being done for right reason eg activity and earnings growth. Particularly like increasing involvement in European renewables. Gms is more than O&G and increasing renewables activity will be good growth and future proofing and hopefully bring broader market appeal than just O&G. Bought at 6p and looking for 12p+. AIMHO.

IMHO the previous share issues to MS and CM are a significant confidence indicator about the license as the share issue was, to my understanding, always intended to be linked to license achievement. We just need patience now for an announcement, which I am positive will take place soon based upon the previous share issue. Ana is my biggest investment right now and I am holding for long term, and hopefully right through to commercial production. GLA.

Apologies if I misunderstand from reading the link below. I think the 6.4m shares issue to the advisor is positive as presumably the advisor has insight into the companies forward potential and has taken equity rather than cash because they believe it will yield a bigger return. The update also tells of the issue of 100m shares each to MS and CM which they should have had some months back when the license should have been originally granted although wasn't due to the Home Office covid enforced delay. These allocations are 0.2p shares accordingly. Think there should always be some caution about share issuance and potential dilution, however, these allocations seem to be linked to essential start up and growth and, IMHO, auger well as the 2*100m lots would not be allocated now if there was not confidence about the license. Apologies once again if I misunderstand, this is just my interpretation and happy to be corrected, but overall I think the update should be interpreted positively IMHO.

Potential uses of medicinal cannabis for covid treatment, dementia and parkinsons particularly interesting. Seems there's already been some anti-viral research linked to sars too?